nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0544	0.0879	CbGbCtD
Temozolomide—CYP3A4—Felbamate—epilepsy syndrome	0.0505	0.0817	CbGbCtD
Temozolomide—CYP3A4—Trimethadione—epilepsy syndrome	0.0505	0.0817	CbGbCtD
Temozolomide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0475	0.0768	CbGbCtD
Temozolomide—CYP3A4—Clonazepam—epilepsy syndrome	0.043	0.0695	CbGbCtD
Temozolomide—CYP3A4—Clobazam—epilepsy syndrome	0.0412	0.0666	CbGbCtD
Temozolomide—CYP3A4—Rufinamide—epilepsy syndrome	0.035	0.0566	CbGbCtD
Temozolomide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0341	0.0552	CbGbCtD
Temozolomide—CYP3A4—Primidone—epilepsy syndrome	0.0319	0.0515	CbGbCtD
Temozolomide—CYP3A4—Phenytoin—epilepsy syndrome	0.0306	0.0495	CbGbCtD
Temozolomide—CYP3A4—Propofol—epilepsy syndrome	0.0286	0.0462	CbGbCtD
Temozolomide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0273	0.0441	CbGbCtD
Temozolomide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0273	0.0441	CbGbCtD
Temozolomide—CYP3A4—Midazolam—epilepsy syndrome	0.0269	0.0435	CbGbCtD
Temozolomide—CYP3A4—Diazepam—epilepsy syndrome	0.0259	0.0418	CbGbCtD
Temozolomide—CYP3A4—Zonisamide—epilepsy syndrome	0.0253	0.0408	CbGbCtD
Temozolomide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0204	0.033	CbGbCtD
Temozolomide—CYP3A4—Topiramate—epilepsy syndrome	0.0184	0.0297	CbGbCtD
Temozolomide—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.23e-05	0.000163	CcSEcCtD
Temozolomide—Vision blurred—Gabapentin—epilepsy syndrome	6.22e-05	0.000163	CcSEcCtD
Temozolomide—Headache—Vigabatrin—epilepsy syndrome	6.21e-05	0.000163	CcSEcCtD
Temozolomide—Hypertension—Pregabalin—epilepsy syndrome	6.21e-05	0.000163	CcSEcCtD
Temozolomide—Vomiting—Diazepam—epilepsy syndrome	6.21e-05	0.000163	CcSEcCtD
Temozolomide—Anorexia—Valproic Acid—epilepsy syndrome	6.19e-05	0.000162	CcSEcCtD
Temozolomide—Tremor—Gabapentin—epilepsy syndrome	6.18e-05	0.000162	CcSEcCtD
Temozolomide—Rash—Diazepam—epilepsy syndrome	6.16e-05	0.000161	CcSEcCtD
Temozolomide—Dermatitis—Diazepam—epilepsy syndrome	6.15e-05	0.000161	CcSEcCtD
Temozolomide—Visual impairment—Topiramate—epilepsy syndrome	6.14e-05	0.000161	CcSEcCtD
Temozolomide—Arthralgia—Pregabalin—epilepsy syndrome	6.12e-05	0.000161	CcSEcCtD
Temozolomide—Myalgia—Pregabalin—epilepsy syndrome	6.12e-05	0.000161	CcSEcCtD
Temozolomide—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.12e-05	0.00016	CcSEcCtD
Temozolomide—Dizziness—Zonisamide—epilepsy syndrome	6.12e-05	0.00016	CcSEcCtD
Temozolomide—Headache—Diazepam—epilepsy syndrome	6.12e-05	0.00016	CcSEcCtD
Temozolomide—Anxiety—Pregabalin—epilepsy syndrome	6.1e-05	0.00016	CcSEcCtD
Temozolomide—Diarrhoea—Clonazepam—epilepsy syndrome	6.1e-05	0.00016	CcSEcCtD
Temozolomide—Anaemia—Gabapentin—epilepsy syndrome	6.1e-05	0.00016	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.08e-05	0.000159	CcSEcCtD
Temozolomide—Asthenia—Carbamazepine—epilepsy syndrome	6.07e-05	0.000159	CcSEcCtD
Temozolomide—Agitation—Gabapentin—epilepsy syndrome	6.06e-05	0.000159	CcSEcCtD
Temozolomide—Diarrhoea—Phenytoin—epilepsy syndrome	6.06e-05	0.000159	CcSEcCtD
Temozolomide—Discomfort—Pregabalin—epilepsy syndrome	6.05e-05	0.000159	CcSEcCtD
Temozolomide—Nausea—Fosphenytoin—epilepsy syndrome	6.04e-05	0.000159	CcSEcCtD
Temozolomide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000158	CcSEcCtD
Temozolomide—Erythema multiforme—Topiramate—epilepsy syndrome	6.03e-05	0.000158	CcSEcCtD
Temozolomide—Angioedema—Gabapentin—epilepsy syndrome	6.03e-05	0.000158	CcSEcCtD
Temozolomide—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.02e-05	0.000158	CcSEcCtD
Temozolomide—Vomiting—Felbamate—epilepsy syndrome	6.01e-05	0.000158	CcSEcCtD
Temozolomide—Dry mouth—Pregabalin—epilepsy syndrome	5.99e-05	0.000157	CcSEcCtD
Temozolomide—Pruritus—Carbamazepine—epilepsy syndrome	5.98e-05	0.000157	CcSEcCtD
Temozolomide—Rash—Felbamate—epilepsy syndrome	5.96e-05	0.000156	CcSEcCtD
Temozolomide—Eye disorder—Topiramate—epilepsy syndrome	5.96e-05	0.000156	CcSEcCtD
Temozolomide—Dermatitis—Felbamate—epilepsy syndrome	5.95e-05	0.000156	CcSEcCtD
Temozolomide—Malaise—Gabapentin—epilepsy syndrome	5.95e-05	0.000156	CcSEcCtD
Temozolomide—Tinnitus—Topiramate—epilepsy syndrome	5.94e-05	0.000156	CcSEcCtD
Temozolomide—Vertigo—Gabapentin—epilepsy syndrome	5.93e-05	0.000155	CcSEcCtD
Temozolomide—Headache—Felbamate—epilepsy syndrome	5.92e-05	0.000155	CcSEcCtD
Temozolomide—Confusional state—Pregabalin—epilepsy syndrome	5.92e-05	0.000155	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.92e-05	0.000155	CcSEcCtD
Temozolomide—Flushing—Topiramate—epilepsy syndrome	5.92e-05	0.000155	CcSEcCtD
Temozolomide—Cardiac disorder—Topiramate—epilepsy syndrome	5.92e-05	0.000155	CcSEcCtD
Temozolomide—Leukopenia—Gabapentin—epilepsy syndrome	5.9e-05	0.000155	CcSEcCtD
Temozolomide—Dizziness—Clonazepam—epilepsy syndrome	5.9e-05	0.000155	CcSEcCtD
Temozolomide—Nausea—Vigabatrin—epilepsy syndrome	5.89e-05	0.000155	CcSEcCtD
Temozolomide—Vomiting—Zonisamide—epilepsy syndrome	5.88e-05	0.000154	CcSEcCtD
Temozolomide—Insomnia—Valproic Acid—epilepsy syndrome	5.87e-05	0.000154	CcSEcCtD
Temozolomide—Oedema—Pregabalin—epilepsy syndrome	5.87e-05	0.000154	CcSEcCtD
Temozolomide—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.87e-05	0.000154	CcSEcCtD
Temozolomide—Asthenia—Lamotrigine—epilepsy syndrome	5.86e-05	0.000154	CcSEcCtD
Temozolomide—Dizziness—Phenytoin—epilepsy syndrome	5.86e-05	0.000154	CcSEcCtD
Temozolomide—Rash—Zonisamide—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Infection—Pregabalin—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Paraesthesia—Valproic Acid—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Palpitations—Gabapentin—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Dermatitis—Zonisamide—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Dizziness—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000153	CcSEcCtD
Temozolomide—Nausea—Diazepam—epilepsy syndrome	5.8e-05	0.000152	CcSEcCtD
Temozolomide—Headache—Zonisamide—epilepsy syndrome	5.8e-05	0.000152	CcSEcCtD
Temozolomide—Dyspnoea—Valproic Acid—epilepsy syndrome	5.79e-05	0.000152	CcSEcCtD
Temozolomide—Diarrhoea—Carbamazepine—epilepsy syndrome	5.78e-05	0.000152	CcSEcCtD
Temozolomide—Angiopathy—Topiramate—epilepsy syndrome	5.78e-05	0.000152	CcSEcCtD
Temozolomide—Pruritus—Lamotrigine—epilepsy syndrome	5.78e-05	0.000152	CcSEcCtD
Temozolomide—Somnolence—Valproic Acid—epilepsy syndrome	5.77e-05	0.000151	CcSEcCtD
Temozolomide—Immune system disorder—Topiramate—epilepsy syndrome	5.76e-05	0.000151	CcSEcCtD
Temozolomide—Nervous system disorder—Pregabalin—epilepsy syndrome	5.76e-05	0.000151	CcSEcCtD
Temozolomide—Cough—Gabapentin—epilepsy syndrome	5.75e-05	0.000151	CcSEcCtD
Temozolomide—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.75e-05	0.000151	CcSEcCtD
Temozolomide—Mediastinal disorder—Topiramate—epilepsy syndrome	5.74e-05	0.000151	CcSEcCtD
Temozolomide—Chills—Topiramate—epilepsy syndrome	5.72e-05	0.00015	CcSEcCtD
Temozolomide—Dyspepsia—Valproic Acid—epilepsy syndrome	5.72e-05	0.00015	CcSEcCtD
Temozolomide—Convulsion—Gabapentin—epilepsy syndrome	5.71e-05	0.00015	CcSEcCtD
Temozolomide—Skin disorder—Pregabalin—epilepsy syndrome	5.7e-05	0.00015	CcSEcCtD
Temozolomide—Hypertension—Gabapentin—epilepsy syndrome	5.69e-05	0.000149	CcSEcCtD
Temozolomide—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.67e-05	0.000149	CcSEcCtD
Temozolomide—Vomiting—Clonazepam—epilepsy syndrome	5.67e-05	0.000149	CcSEcCtD
Temozolomide—Decreased appetite—Valproic Acid—epilepsy syndrome	5.64e-05	0.000148	CcSEcCtD
Temozolomide—Alopecia—Topiramate—epilepsy syndrome	5.63e-05	0.000148	CcSEcCtD
Temozolomide—Vomiting—Phenytoin—epilepsy syndrome	5.63e-05	0.000148	CcSEcCtD
Temozolomide—Rash—Clonazepam—epilepsy syndrome	5.62e-05	0.000147	CcSEcCtD
Temozolomide—Dermatitis—Clonazepam—epilepsy syndrome	5.62e-05	0.000147	CcSEcCtD
Temozolomide—Myalgia—Gabapentin—epilepsy syndrome	5.61e-05	0.000147	CcSEcCtD
Temozolomide—Arthralgia—Gabapentin—epilepsy syndrome	5.61e-05	0.000147	CcSEcCtD
Temozolomide—Nausea—Felbamate—epilepsy syndrome	5.61e-05	0.000147	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.61e-05	0.000147	CcSEcCtD
Temozolomide—Vomiting—Oxcarbazepine—epilepsy syndrome	5.6e-05	0.000147	CcSEcCtD
Temozolomide—Fatigue—Valproic Acid—epilepsy syndrome	5.6e-05	0.000147	CcSEcCtD
Temozolomide—Anxiety—Gabapentin—epilepsy syndrome	5.6e-05	0.000147	CcSEcCtD
Temozolomide—Anorexia—Pregabalin—epilepsy syndrome	5.6e-05	0.000147	CcSEcCtD
Temozolomide—Dizziness—Carbamazepine—epilepsy syndrome	5.59e-05	0.000147	CcSEcCtD
Temozolomide—Diarrhoea—Lamotrigine—epilepsy syndrome	5.59e-05	0.000147	CcSEcCtD
Temozolomide—Headache—Clonazepam—epilepsy syndrome	5.59e-05	0.000146	CcSEcCtD
Temozolomide—Rash—Phenytoin—epilepsy syndrome	5.58e-05	0.000146	CcSEcCtD
Temozolomide—Mental disorder—Topiramate—epilepsy syndrome	5.58e-05	0.000146	CcSEcCtD
Temozolomide—Dermatitis—Phenytoin—epilepsy syndrome	5.58e-05	0.000146	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.58e-05	0.000146	CcSEcCtD
Temozolomide—Rash—Oxcarbazepine—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Constipation—Valproic Acid—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Pain—Valproic Acid—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Headache—Phenytoin—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Malnutrition—Topiramate—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Erythema—Topiramate—epilepsy syndrome	5.55e-05	0.000146	CcSEcCtD
Temozolomide—Discomfort—Gabapentin—epilepsy syndrome	5.55e-05	0.000145	CcSEcCtD
Temozolomide—Headache—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.000145	CcSEcCtD
Temozolomide—Nausea—Zonisamide—epilepsy syndrome	5.5e-05	0.000144	CcSEcCtD
Temozolomide—Dry mouth—Gabapentin—epilepsy syndrome	5.49e-05	0.000144	CcSEcCtD
Temozolomide—Dysgeusia—Topiramate—epilepsy syndrome	5.43e-05	0.000142	CcSEcCtD
Temozolomide—Confusional state—Gabapentin—epilepsy syndrome	5.43e-05	0.000142	CcSEcCtD
Temozolomide—Dizziness—Lamotrigine—epilepsy syndrome	5.4e-05	0.000142	CcSEcCtD
Temozolomide—Oedema—Gabapentin—epilepsy syndrome	5.38e-05	0.000141	CcSEcCtD
Temozolomide—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.38e-05	0.000141	CcSEcCtD
Temozolomide—Vomiting—Carbamazepine—epilepsy syndrome	5.38e-05	0.000141	CcSEcCtD
Temozolomide—Back pain—Topiramate—epilepsy syndrome	5.37e-05	0.000141	CcSEcCtD
Temozolomide—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.35e-05	0.00014	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.35e-05	0.00014	CcSEcCtD
Temozolomide—Infection—Gabapentin—epilepsy syndrome	5.35e-05	0.00014	CcSEcCtD
Temozolomide—Rash—Carbamazepine—epilepsy syndrome	5.33e-05	0.00014	CcSEcCtD
Temozolomide—Dermatitis—Carbamazepine—epilepsy syndrome	5.33e-05	0.00014	CcSEcCtD
Temozolomide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.31e-05	0.000139	CcSEcCtD
Temozolomide—Insomnia—Pregabalin—epilepsy syndrome	5.31e-05	0.000139	CcSEcCtD
Temozolomide—Nausea—Clonazepam—epilepsy syndrome	5.3e-05	0.000139	CcSEcCtD
Temozolomide—Headache—Carbamazepine—epilepsy syndrome	5.3e-05	0.000139	CcSEcCtD
Temozolomide—Nervous system disorder—Gabapentin—epilepsy syndrome	5.28e-05	0.000138	CcSEcCtD
Temozolomide—Paraesthesia—Pregabalin—epilepsy syndrome	5.27e-05	0.000138	CcSEcCtD
Temozolomide—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.27e-05	0.000138	CcSEcCtD
Temozolomide—Nausea—Phenytoin—epilepsy syndrome	5.26e-05	0.000138	CcSEcCtD
Temozolomide—Dyspnoea—Pregabalin—epilepsy syndrome	5.23e-05	0.000137	CcSEcCtD
Temozolomide—Nausea—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000137	CcSEcCtD
Temozolomide—Vision blurred—Topiramate—epilepsy syndrome	5.23e-05	0.000137	CcSEcCtD
Temozolomide—Skin disorder—Gabapentin—epilepsy syndrome	5.23e-05	0.000137	CcSEcCtD
Temozolomide—Somnolence—Pregabalin—epilepsy syndrome	5.22e-05	0.000137	CcSEcCtD
Temozolomide—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.2e-05	0.000136	CcSEcCtD
Temozolomide—Tremor—Topiramate—epilepsy syndrome	5.2e-05	0.000136	CcSEcCtD
Temozolomide—Vomiting—Lamotrigine—epilepsy syndrome	5.2e-05	0.000136	CcSEcCtD
Temozolomide—Urticaria—Valproic Acid—epilepsy syndrome	5.16e-05	0.000135	CcSEcCtD
Temozolomide—Rash—Lamotrigine—epilepsy syndrome	5.15e-05	0.000135	CcSEcCtD
Temozolomide—Ill-defined disorder—Topiramate—epilepsy syndrome	5.15e-05	0.000135	CcSEcCtD
Temozolomide—Dermatitis—Lamotrigine—epilepsy syndrome	5.15e-05	0.000135	CcSEcCtD
Temozolomide—Abdominal pain—Valproic Acid—epilepsy syndrome	5.13e-05	0.000135	CcSEcCtD
Temozolomide—Body temperature increased—Valproic Acid—epilepsy syndrome	5.13e-05	0.000135	CcSEcCtD
Temozolomide—Anorexia—Gabapentin—epilepsy syndrome	5.13e-05	0.000135	CcSEcCtD
Temozolomide—Anaemia—Topiramate—epilepsy syndrome	5.13e-05	0.000134	CcSEcCtD
Temozolomide—Headache—Lamotrigine—epilepsy syndrome	5.12e-05	0.000134	CcSEcCtD
Temozolomide—Decreased appetite—Pregabalin—epilepsy syndrome	5.1e-05	0.000134	CcSEcCtD
Temozolomide—Agitation—Topiramate—epilepsy syndrome	5.1e-05	0.000134	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.07e-05	0.000133	CcSEcCtD
Temozolomide—Fatigue—Pregabalin—epilepsy syndrome	5.06e-05	0.000133	CcSEcCtD
Temozolomide—Nausea—Carbamazepine—epilepsy syndrome	5.02e-05	0.000132	CcSEcCtD
Temozolomide—Pain—Pregabalin—epilepsy syndrome	5.02e-05	0.000132	CcSEcCtD
Temozolomide—Constipation—Pregabalin—epilepsy syndrome	5.02e-05	0.000132	CcSEcCtD
Temozolomide—Malaise—Topiramate—epilepsy syndrome	5e-05	0.000131	CcSEcCtD
Temozolomide—Vertigo—Topiramate—epilepsy syndrome	4.99e-05	0.000131	CcSEcCtD
Temozolomide—Leukopenia—Topiramate—epilepsy syndrome	4.97e-05	0.00013	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.9e-05	0.000129	CcSEcCtD
Temozolomide—Palpitations—Topiramate—epilepsy syndrome	4.9e-05	0.000129	CcSEcCtD
Temozolomide—Insomnia—Gabapentin—epilepsy syndrome	4.87e-05	0.000128	CcSEcCtD
Temozolomide—Nausea—Lamotrigine—epilepsy syndrome	4.85e-05	0.000127	CcSEcCtD
Temozolomide—Cough—Topiramate—epilepsy syndrome	4.84e-05	0.000127	CcSEcCtD
Temozolomide—Feeling abnormal—Pregabalin—epilepsy syndrome	4.84e-05	0.000127	CcSEcCtD
Temozolomide—Paraesthesia—Gabapentin—epilepsy syndrome	4.83e-05	0.000127	CcSEcCtD
Temozolomide—Convulsion—Topiramate—epilepsy syndrome	4.81e-05	0.000126	CcSEcCtD
Temozolomide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.8e-05	0.000126	CcSEcCtD
Temozolomide—Dyspnoea—Gabapentin—epilepsy syndrome	4.8e-05	0.000126	CcSEcCtD
Temozolomide—Hypertension—Topiramate—epilepsy syndrome	4.79e-05	0.000126	CcSEcCtD
Temozolomide—Somnolence—Gabapentin—epilepsy syndrome	4.79e-05	0.000125	CcSEcCtD
Temozolomide—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.78e-05	0.000125	CcSEcCtD
Temozolomide—Dyspepsia—Gabapentin—epilepsy syndrome	4.74e-05	0.000124	CcSEcCtD
Temozolomide—Arthralgia—Topiramate—epilepsy syndrome	4.72e-05	0.000124	CcSEcCtD
Temozolomide—Myalgia—Topiramate—epilepsy syndrome	4.72e-05	0.000124	CcSEcCtD
Temozolomide—Anxiety—Topiramate—epilepsy syndrome	4.71e-05	0.000123	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.69e-05	0.000123	CcSEcCtD
Temozolomide—Decreased appetite—Gabapentin—epilepsy syndrome	4.68e-05	0.000123	CcSEcCtD
Temozolomide—Discomfort—Topiramate—epilepsy syndrome	4.67e-05	0.000122	CcSEcCtD
Temozolomide—Urticaria—Pregabalin—epilepsy syndrome	4.66e-05	0.000122	CcSEcCtD
Temozolomide—Asthenia—Valproic Acid—epilepsy syndrome	4.66e-05	0.000122	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.65e-05	0.000122	CcSEcCtD
Temozolomide—Fatigue—Gabapentin—epilepsy syndrome	4.64e-05	0.000122	CcSEcCtD
Temozolomide—Abdominal pain—Pregabalin—epilepsy syndrome	4.64e-05	0.000122	CcSEcCtD
Temozolomide—Body temperature increased—Pregabalin—epilepsy syndrome	4.64e-05	0.000122	CcSEcCtD
Temozolomide—Dry mouth—Topiramate—epilepsy syndrome	4.62e-05	0.000121	CcSEcCtD
Temozolomide—Pain—Gabapentin—epilepsy syndrome	4.6e-05	0.000121	CcSEcCtD
Temozolomide—Constipation—Gabapentin—epilepsy syndrome	4.6e-05	0.000121	CcSEcCtD
Temozolomide—Pruritus—Valproic Acid—epilepsy syndrome	4.59e-05	0.00012	CcSEcCtD
Temozolomide—Confusional state—Topiramate—epilepsy syndrome	4.57e-05	0.00012	CcSEcCtD
Temozolomide—Oedema—Topiramate—epilepsy syndrome	4.53e-05	0.000119	CcSEcCtD
Temozolomide—Infection—Topiramate—epilepsy syndrome	4.5e-05	0.000118	CcSEcCtD
Temozolomide—Diarrhoea—Valproic Acid—epilepsy syndrome	4.44e-05	0.000117	CcSEcCtD
Temozolomide—Nervous system disorder—Topiramate—epilepsy syndrome	4.44e-05	0.000116	CcSEcCtD
Temozolomide—Feeling abnormal—Gabapentin—epilepsy syndrome	4.44e-05	0.000116	CcSEcCtD
Temozolomide—Thrombocytopenia—Topiramate—epilepsy syndrome	4.43e-05	0.000116	CcSEcCtD
Temozolomide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.4e-05	0.000115	CcSEcCtD
Temozolomide—Skin disorder—Topiramate—epilepsy syndrome	4.4e-05	0.000115	CcSEcCtD
Temozolomide—Hyperhidrosis—Topiramate—epilepsy syndrome	4.38e-05	0.000115	CcSEcCtD
Temozolomide—Hypersensitivity—Pregabalin—epilepsy syndrome	4.32e-05	0.000113	CcSEcCtD
Temozolomide—Anorexia—Topiramate—epilepsy syndrome	4.32e-05	0.000113	CcSEcCtD
Temozolomide—Dizziness—Valproic Acid—epilepsy syndrome	4.29e-05	0.000113	CcSEcCtD
Temozolomide—Urticaria—Gabapentin—epilepsy syndrome	4.28e-05	0.000112	CcSEcCtD
Temozolomide—Abdominal pain—Gabapentin—epilepsy syndrome	4.25e-05	0.000112	CcSEcCtD
Temozolomide—Body temperature increased—Gabapentin—epilepsy syndrome	4.25e-05	0.000112	CcSEcCtD
Temozolomide—Asthenia—Pregabalin—epilepsy syndrome	4.21e-05	0.00011	CcSEcCtD
Temozolomide—Pruritus—Pregabalin—epilepsy syndrome	4.15e-05	0.000109	CcSEcCtD
Temozolomide—Vomiting—Valproic Acid—epilepsy syndrome	4.13e-05	0.000108	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.13e-05	0.000108	CcSEcCtD
Temozolomide—Insomnia—Topiramate—epilepsy syndrome	4.1e-05	0.000107	CcSEcCtD
Temozolomide—Rash—Valproic Acid—epilepsy syndrome	4.09e-05	0.000107	CcSEcCtD
Temozolomide—Dermatitis—Valproic Acid—epilepsy syndrome	4.09e-05	0.000107	CcSEcCtD
Temozolomide—Headache—Valproic Acid—epilepsy syndrome	4.07e-05	0.000107	CcSEcCtD
Temozolomide—Paraesthesia—Topiramate—epilepsy syndrome	4.07e-05	0.000107	CcSEcCtD
Temozolomide—Dyspnoea—Topiramate—epilepsy syndrome	4.04e-05	0.000106	CcSEcCtD
Temozolomide—Somnolence—Topiramate—epilepsy syndrome	4.03e-05	0.000106	CcSEcCtD
Temozolomide—Diarrhoea—Pregabalin—epilepsy syndrome	4.02e-05	0.000105	CcSEcCtD
Temozolomide—Dyspepsia—Topiramate—epilepsy syndrome	3.99e-05	0.000105	CcSEcCtD
Temozolomide—Hypersensitivity—Gabapentin—epilepsy syndrome	3.97e-05	0.000104	CcSEcCtD
Temozolomide—Decreased appetite—Topiramate—epilepsy syndrome	3.94e-05	0.000103	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.91e-05	0.000103	CcSEcCtD
Temozolomide—Fatigue—Topiramate—epilepsy syndrome	3.9e-05	0.000102	CcSEcCtD
Temozolomide—Dizziness—Pregabalin—epilepsy syndrome	3.88e-05	0.000102	CcSEcCtD
Temozolomide—Pain—Topiramate—epilepsy syndrome	3.87e-05	0.000102	CcSEcCtD
Temozolomide—Constipation—Topiramate—epilepsy syndrome	3.87e-05	0.000102	CcSEcCtD
Temozolomide—Asthenia—Gabapentin—epilepsy syndrome	3.86e-05	0.000101	CcSEcCtD
Temozolomide—Nausea—Valproic Acid—epilepsy syndrome	3.86e-05	0.000101	CcSEcCtD
Temozolomide—Pruritus—Gabapentin—epilepsy syndrome	3.81e-05	9.99e-05	CcSEcCtD
Temozolomide—Vomiting—Pregabalin—epilepsy syndrome	3.73e-05	9.79e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Topiramate—epilepsy syndrome	3.73e-05	9.79e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.7e-05	9.71e-05	CcSEcCtD
Temozolomide—Rash—Pregabalin—epilepsy syndrome	3.7e-05	9.71e-05	CcSEcCtD
Temozolomide—Dermatitis—Pregabalin—epilepsy syndrome	3.7e-05	9.7e-05	CcSEcCtD
Temozolomide—Diarrhoea—Gabapentin—epilepsy syndrome	3.68e-05	9.66e-05	CcSEcCtD
Temozolomide—Headache—Pregabalin—epilepsy syndrome	3.68e-05	9.64e-05	CcSEcCtD
Temozolomide—Urticaria—Topiramate—epilepsy syndrome	3.6e-05	9.43e-05	CcSEcCtD
Temozolomide—Body temperature increased—Topiramate—epilepsy syndrome	3.58e-05	9.39e-05	CcSEcCtD
Temozolomide—Abdominal pain—Topiramate—epilepsy syndrome	3.58e-05	9.39e-05	CcSEcCtD
Temozolomide—Dizziness—Gabapentin—epilepsy syndrome	3.56e-05	9.33e-05	CcSEcCtD
Temozolomide—Nausea—Pregabalin—epilepsy syndrome	3.49e-05	9.14e-05	CcSEcCtD
Temozolomide—Vomiting—Gabapentin—epilepsy syndrome	3.42e-05	8.97e-05	CcSEcCtD
Temozolomide—Rash—Gabapentin—epilepsy syndrome	3.39e-05	8.9e-05	CcSEcCtD
Temozolomide—Dermatitis—Gabapentin—epilepsy syndrome	3.39e-05	8.89e-05	CcSEcCtD
Temozolomide—Headache—Gabapentin—epilepsy syndrome	3.37e-05	8.84e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Topiramate—epilepsy syndrome	3.34e-05	8.75e-05	CcSEcCtD
Temozolomide—Asthenia—Topiramate—epilepsy syndrome	3.25e-05	8.52e-05	CcSEcCtD
Temozolomide—Pruritus—Topiramate—epilepsy syndrome	3.2e-05	8.4e-05	CcSEcCtD
Temozolomide—Nausea—Gabapentin—epilepsy syndrome	3.2e-05	8.38e-05	CcSEcCtD
Temozolomide—Diarrhoea—Topiramate—epilepsy syndrome	3.1e-05	8.13e-05	CcSEcCtD
Temozolomide—Dizziness—Topiramate—epilepsy syndrome	2.99e-05	7.85e-05	CcSEcCtD
Temozolomide—Vomiting—Topiramate—epilepsy syndrome	2.88e-05	7.55e-05	CcSEcCtD
Temozolomide—Rash—Topiramate—epilepsy syndrome	2.86e-05	7.49e-05	CcSEcCtD
Temozolomide—Dermatitis—Topiramate—epilepsy syndrome	2.85e-05	7.48e-05	CcSEcCtD
Temozolomide—Headache—Topiramate—epilepsy syndrome	2.84e-05	7.44e-05	CcSEcCtD
Temozolomide—Nausea—Topiramate—epilepsy syndrome	2.69e-05	7.05e-05	CcSEcCtD
